Intest Corporation shares rise 1.07% after-hours following Swedish study on type 2 diabetes and cardiovascular risks.

Intest Corporation rose 1.07% in after-hours trading, following the release of a Swedish study on type 2 diabetes and cardiovascular diseases. The study, which involved 752 volunteers, could help doctors identify those at low risk for developing cardiovascular diseases versus those at higher risk. This news is relevant to Intest Corporation, as it may indicate a potential market for their products or services related to diabetes and cardiovascular health.